It blocks interaction of PD-1 on T-cells with PD-L1 and programmed death ligand-2 (PD-L2) on tumor cells and allows for tumor antigen-specific T-cell proliferation and cytokine release (27). This evidence concerns the gene PDCD1 and neoplasm.